Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (346)

Clear all filters
Clear all filters

Zilovertamab Vedotin

Targeted Therapy (Antibody-Drug Conjugate)

Therapeutic Category

Targeted Therapy (Antibody-Drug Conjugate)

Oncology Type

Solid Tumour

Drug Class / Mechanism

ADC

Ziv-Aflibercept

Targeted Therapy (Antibody)

Therapeutic Category

Targeted Therapy (Antibody)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Anti-VEGF / VEGFR Agent

Zorifertinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

EGFR / HER2 Tyrosine Kinase Inhibitor

Fulzerasib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

KRAS G12C Covalent Inhibitor

Sugemalimab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Anti-PD-L1 Monoclonal Antibody

Acasunlimab

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Bispecific Antibody, PD-L1 x 4-1BB Conditional Agonist

Anetumab Ravtansine

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

AT7519 (CDK Inhibitor)

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Solid Tumour (Sarcoma)

Drug Class / Mechanism

Gamma-Secretase / CDK Inhibitor

AZD4547 (Investigational FGFR)

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

FGFR Inhibitor

Bemarituzumab

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

BMS-986156 (GITR)

Immunotherapy (Investigational)

Therapeutic Category

Immunotherapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Costimulatory / Bispecific Agent

BMS-986205 (Linrodostat)

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)